Back to today’s briefing

Story perspectives

Revolutionary Hormone-Free Male Contraceptive Pill Enters Trials

4/1/2025

24 5

Summary

Story summary

YCT-529, a groundbreaking hormone-free male contraceptive pill, has demonstrated remarkable success in animal trials, preventing 99% of pregnancies in mice and drastically lowering sperm counts in primates. With human clinical trials kicking off in December 2023, this innovation holds the potential to empower men with a dependable birth control method, reshaping reproductive responsibility.

1 of 1

Story summary

YCT-529, a groundbreaking hormone-free male contraceptive pill, has demonstrated remarkable success in animal trials, preventing 99% of pregnancies in mice and drastically lowering sperm counts in primates. With human clinical trials kicking off in December 2023, this innovation holds the potential to empower men with a dependable birth control method, reshaping reproductive responsibility.